WYNZORA Drug Patent Profile
✉ Email this page to a colleague
When do Wynzora patents expire, and what generic alternatives are available?
Wynzora is a drug marketed by MC2 and is included in one NDA. There are two patents protecting this drug.
This drug has forty-eight patent family members in twenty-eight countries.
The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
DrugPatentWatch® Generic Entry Outlook for Wynzora
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for WYNZORA?
- What are the global sales for WYNZORA?
- What is Average Wholesale Price for WYNZORA?
Summary for WYNZORA
| International Patents: | 48 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in WYNZORA? | WYNZORA excipients list |
| DailyMed Link: | WYNZORA at DailyMed |
Pharmacology for WYNZORA
| Drug Class | Corticosteroid Vitamin D Analog |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for WYNZORA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mc2 | WYNZORA | betamethasone dipropionate; calcipotriene | CREAM;TOPICAL | 213422-001 | Jul 20, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Mc2 | WYNZORA | betamethasone dipropionate; calcipotriene | CREAM;TOPICAL | 213422-001 | Jul 20, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for WYNZORA
See the table below for patents covering WYNZORA around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Spain | 2896931 | ⤷ Sign Up | |
| Spain | 2368535 | ⤷ Sign Up | |
| Australia | 2019239544 | Topical composition | ⤷ Sign Up |
| Mexico | 2020009764 | COMPOSICION TOPICA. (TOPICAL COMPOSITION.) | ⤷ Sign Up |
| Japan | 2010521445 | ⤷ Sign Up | |
| World Intellectual Property Organization (WIPO) | 2019179958 | ⤷ Sign Up | |
| Japan | 5414542 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
